Despite a significant reduction of tumor growth induced by physical activity (40%, compared to the inactive group receiving PBS, p < 0.05), also in this case the combination of training with the anti-PD-1 did not result in additive effects (50% tumor growth inhibition, exercising versus sedentary groups, p = 0.07) 71. This evidence concerns the gene RPL17 and neoplasm.